Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Roberto M. Lang, Michelle Bierig, Richard B. Devereux et al. · Journal of the American Society of Echocardiography · 2005 · 11.3K citations

Standards Committee, Cardiovascular Disease, Patient Safety +13

Right Ventricular Function and Failure

Norbert F. Voelkel, Robert A. Quaife, Leslie A. Leinwand et al. · Circulation · 2006 · 1.2K citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +5

Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy

Benjamin J. Wilkins, Yan‐Shan Dai, Orlando F. Bueno et al. · Circulation Research · 2003 · 756 citations

Frzb-1 Is a Secreted Antagonist of Wnt Signaling Expressed in the Spemann Organizer

Luc Leyns, Tewis Bouwmeester, Sung‐Hyun Kim et al. · Cell · 1997 · 732 citations · Full text

Signal Transduction, Spemann Organizer, Signaling Pathway +9

Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells

Genevieve M. Boland, Géraldine Perkins, David J. Hall et al. · Journal of Cellular Biochemistry · 2004 · 568 citations